Disease Education Resources
Oncology
Explore our library of Lilly-created medical education resources. Please note: These resources do not offer CME/CE credit.
Hematological Malignancy
Chronic Lymphocytic Leukemia (CLL)
This website contains CLL disease state information with educational resources to help support HCPs in care of patients with CLL.
Clinical Considerations in Treatment Sequencing in CLL (Patient Case)
John Allan, MD, and Melissa Rubianes, PA-C, walk-through a CLL patient case and discuss the clinical considerations for treatment sequencing.
CLL Experts Share their Experience Caring for Patients with CLL
Join chronic lymphocytic leukemia (CLL) providers as they share expert insights on caring for patients with CLL in this video series.
Considerations for First-Line Treatment Selection in CLL
John Allan, MD, and Melissa Rubianes, PA-C, share expert insights on Considerations for First-Line Treatment Selection in CLL.
Learn How Covalent BTKi Progression or Intolerance Impacts Treatment Decisions in CLL
This microlearning video educates HCPs on differentiating BTKi treatment intolerance versus disease progression in CLL to guide appropriate sequencing of subsequent therapies.
Mantle Cell Lymphoma
Here you will find medical slide sets about Mantle Cell Lymphoma (MCL), including a disease overview and risk factors for poor prognosis.
Overview of Hematologic Malignancies
Explore our educational materials and resources on patient care and B-cell malignancies.
Part One: Considerations for Treatment Decisions in CLL After Progression vs Treatment Intolerance
Part One: John Allan, MD, and Melissa Rubianes, PA-C, share expert insights on Considerations or Treatment Decisions in CLL After Progression vs Treatment Intolerance.
Part Two: Considerations for Treatment Decisions in CLL After Progression vs Treatment Intolerance
Part Two: John Allan, MD, and Melissa Rubianes, PA-C, share expert insights on Distinguishing Between CLL Disease Progression and Treatment Intolerance.
Understanding BTK Inhibitors in CLL
This video reviews the role of BTK inhibition in CLL, providing insights into the underlying disease mechanisms and how these inhibitors work to overcome resistance.
Understanding CLL: Disease State Education & Supportive Care Resources
Clinical resources for HCPs on CLL Disease State and Supportive Care.
Understanding Reversible Bruton Tyrosine Kinase (BTK) Inhibition in B Cell Malignancies
Explore our educational materials about BTK inhibition in the treatment of B-cell malignancies, and a growing unmet need of resistance to covalent BTK inhibition.
Video: Navigate Real-World Treatment Decisions in CLL
This video outlines guideline‑based considerations—when to treat, how to monitor response and safety, and the role of molecular testing—to inform patient‑centered decision‑making in chronic lymphocytic leukemia.
This case illustrates treatment decision-making for elderly patients with active CLL - looking at frailty assessment, considerations for first-line treatment selection, and subsequent treatments.
This case illustrates CLL treatment decision making from first‑line to relapse, informed by disease risk and patient preferences.
This deck highlights how distinguishing intolerance from progression in CLL informs treatment sequencing.
Patient Education Resources
Explore our library of patient based education materials to aid in HCP to patient interactions.